Lista de obras -

Angiopoietin-2-driven vascular remodeling in airway inflammation

artículo científico publicado en 2010

Angiopoietin/Tie2 signaling transforms capillaries into venules primed for leukocyte trafficking in airway inflammation

artículo científico publicado en 2010

Angiostatic activity of the antitumor cytokine interleukin-21.

artículo científico publicado en 2008

CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells

artículo científico publicado en 2018

CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL.

artículo científico publicado en 2016

Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance

artículo científico publicado en 2004

Cellular source and amount of vascular endothelial growth factor and platelet-derived growth factor in tumors determine response to angiogenesis inhibitors

artículo científico publicado en 2009

Corrigendum: PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin

artículo científico publicado en 2015

Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer

artículo científico publicado en 2015

GATA2 is required for lymphatic vessel valve development and maintenance.

artículo científico publicado en 2015

GSK3732394: a Multi-specific Inhibitor of HIV Entry

artículo científico publicado en 2019

Genomic Instability Is an Early Event in Aluminium-Induced Tumorigenesis

scientific article published on 07 December 2020

Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL.

artículo científico publicado en 2007

Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells

artículo científico publicado en 2007

MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells

artículo científico publicado en 2013

MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy

artículo científico publicado en 2013

Molecular pathways of angiogenesis inhibition

artículo científico publicado en 2007

NF-kappa B: a new player in angiostatic therapy

artículo científico publicado en 2008

NF-kappaB activation in endothelial cells is critical for the activity of angiostatic agents

artículo científico publicado en 2009

PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.

artículo científico publicado en 2014

Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation

artículo científico publicado en 2011

Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis.

artículo científico publicado en 2006

Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature

artículo científico publicado en 2006

Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways

artículo científico publicado en 2007

Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis

artículo científico publicado en 2010

Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors ⬇️

artículo científico publicado el 24 de febrero de 2012

Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity

artículo científico publicado en 2016

The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-kappaB activation

artículo científico publicado en 2007

The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation

artículo científico publicado en 2011

The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB

artículo científico publicado en 2003

The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases

artículo científico publicado en 2005

miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization.

artículo científico publicado en 2014

Lista de obras de

Angiopoietin-2-driven vascular remodeling in airway inflammation

Angiopoietin/Tie2 signaling transforms capillaries into venules primed for leukocyte trafficking in airway inflammation

Angiostatic activity of the antitumor cytokine interleukin-21.

CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells

CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL.

Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance

Cellular source and amount of vascular endothelial growth factor and platelet-derived growth factor in tumors determine response to angiogenesis inhibitors

Corrigendum: PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin

Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer

GATA2 is required for lymphatic vessel valve development and maintenance.

GSK3732394: a Multi-specific Inhibitor of HIV Entry

Genomic Instability Is an Early Event in Aluminium-Induced Tumorigenesis

Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL.

Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells

MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells

MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy

Molecular pathways of angiogenesis inhibition

NF-kappa B: a new player in angiostatic therapy

NF-kappaB activation in endothelial cells is critical for the activity of angiostatic agents

PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.

Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation

Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis.

Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature

Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways

Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis

Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors ⬇️

Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity

The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-kappaB activation

The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation

The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB

The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases

miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization.